Nobivac Myxo-RHD PLUS
Active substance
ATC code
Species
Rabbits.
Indications
For active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV1) and RHD type 2 virus (RHDV2).
Onset of immunity: 3 weeks.
Duration of immunity: 1 year.
Dose to be administered and administration route
Subcutaneous use.
Primary vaccination:
Administer one dose to rabbits from 5 weeks of age onwards.
Revaccination:
Revaccinate annually.
Ensure that the lyophilisate is completely reconstituted before use.
Reconstituted product: off-pink or pink coloured suspension.
Single dose vial
Reconstitute a single dose vial containing lyophilisate with 0.5 ml of the supplied solvent. Administer the total contents of the vial.
Multi-dose vial (50 doses)
Reconstitute a multi-dose vial containing lyophilisate with 10 ml of the supplied solvent. Administer 0.2 ml per animal.
For proper reconstitution of the multi-dose vial, use the following procedure:
1. Add 1 – 2 ml of solvent to the 50-dose vaccine vial and ensure that the lyophilisate is fully dissolved.
2. Withdraw the reconstituted vaccine concentrate from the vial and inject it back into the solvent vial.
3. Ensure that the resulting vaccine suspension in the solvent vial is properly mixed.
4. Use the vaccine suspension within 4 hours of reconstitution. Any reconstituted vaccine remaining at the end of this time should be discarded.
Adverse reactions
Rabbits:
|
Common (1 to 10 animals / 100 animals treated): |
Hyperthermia1, Injection site swelling.2 |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Injection site necrosis3, injection site scab3, injection site crust3, injection site hair loss3. Hypersensitivity reaction4. Myxomatosis5. Anorexia, lethargy. |
1 Transient temperature increase of 1 – 2 °C
2 A small, non-painful swelling (maximum 2 cm diameter) within the first two weeks after vaccination. The swelling will resolve completely by 3 weeks after vaccination.
3 In pet rabbits.
4 Sometimes fatal.
5 Mild clinical signs of myxomatosis may occur within 3 weeks of vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
TRUSTED SOURCE
